Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) — Financial Flexibility Index
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥24.82 Million (operating CF CN¥15.57 Million minus capex CN¥9.26 Million) represents 0% of total liabilities (CN¥373.70 Million). Check Wuhan Easy Diagnosis Biomedicine Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A across 15 annual periods. For the full cash flow conversion analysis, see Wuhan Easy Diagnosis Biomedicine Co Ltd (002932) cash flow conversion.
Annual Financial Flexibility Index for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)
Year-by-year free cash flow to debt coverage for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A. Explore Wuhan Easy Diagnosis Biomedicine Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥20.84 Million | CN¥-70.05 Million | CN¥324.56 Million | ▼ -63.0% |
| 2024 | 0.17x | CN¥99.72 Million | CN¥-85.05 Million | CN¥574.40 Million | ▼ -62.2% |
| 2023 | 0.46x | CN¥502.47 Million | CN¥392.50 Million | CN¥1.09 Billion | ▼ -74.3% |
| 2022 | 1.79x | CN¥4.33 Billion | CN¥4.01 Billion | CN¥2.42 Billion | ▼ -17.6% |
| 2021 | 2.17x | CN¥1.23 Billion | CN¥1.13 Billion | CN¥567.02 Million | ▲ +74.4% |
| 2020 | 1.24x | CN¥387.97 Million | CN¥359.68 Million | CN¥311.77 Million | ▼ -47.9% |
| 2019 | 2.39x | CN¥54.42 Million | CN¥22.49 Million | CN¥22.80 Million | ▼ -42.1% |
| 2018 | 4.12x | CN¥101.15 Million | CN¥53.67 Million | CN¥24.55 Million | ▼ -39.1% |
| 2017 | 6.76x | CN¥92.01 Million | CN¥46.50 Million | CN¥13.60 Million | ▲ +50.6% |
| 2016 | 4.49x | CN¥99.13 Million | CN¥58.86 Million | CN¥22.07 Million | ▲ +80.5% |
| 2015 | 2.49x | CN¥46.20 Million | CN¥45.02 Million | CN¥18.57 Million | ▲ +37.2% |
| 2014 | 1.81x | CN¥20.71 Million | CN¥16.47 Million | CN¥11.42 Million | ▲ +104.7% |
| 2013 | 0.89x | CN¥9.03 Million | CN¥6.30 Million | CN¥10.19 Million | ▲ +77.3% |
| 2012 | 0.50x | CN¥1.62 Million | CN¥1.03 Million | CN¥3.23 Million | ▲ +369.2% |
| 2011 | -0.19x | CN¥-359.32K | CN¥-482.90K | CN¥1.94 Million | — |